Shattuck Labs Inc - שווי שוק בספרים STTK

The available price movement vector for Shattuck Labs, Inc. (STTK) on GURU.Markets is currently at 0.21. Shattuck Labs, Inc. (STTK) develops immunotherapy via the ARC system, with expectations for SL-172154 to succeed in combating leukemia. The business model relies on external protein synthesis, providing financial leverage upon FDA approval. Project success depends on the outcomes of oncology drug trials, while market capitalization remains stable.

Book value capitalization reflects the net value of the business, representing the difference between all assets and the total liabilities of the company. By analyzing the total book capitalization, an investor assesses the actual amount of equity in Shattuck Labs, Inc. (STTK), which is critical given the high burn rate for protein clinical trials and the risk of share dilution during new issuances.